Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
about
The isoprenoid derivative N6 -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway.N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines.The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.
P2860
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Antiglioma effects of N6-isope ...... dermal growth factor receptor.
@en
type
label
Antiglioma effects of N6-isope ...... dermal growth factor receptor.
@en
prefLabel
Antiglioma effects of N6-isope ...... dermal growth factor receptor.
@en
P2093
P2860
P356
P1476
Antiglioma effects of N6-isope ...... idermal growth factor receptor
@en
P2093
Chiara Laezza
Elena Ciaglia
Giovanni Torelli
Mario Vitale
Maurizio Bifulco
Patrizia Gazzerro
Silvia Franceschelli
Simona Pisanti
Vincenzo Seneca
P2860
P304
P356
10.1002/IJC.30505
P577
2016-11-16T00:00:00Z